Braingaze

Braingaze is a digital health company founded in 2013 as a spin-off from the University of Barcelona, with offices in Barcelona, Spain, and Surrey, UK. The company focuses on developing diagnostic and therapeutic solutions for neurodevelopmental disorders, including ADHD, Autism Spectrum Disorder, and Alzheimer's Disease. Braingaze utilizes over 20 years of neuroscientific research on involuntary eye movements as biomarkers for cognitive function. The core product, BGaze Clinic, is a diagnostic support system that employs advanced eye-tracking technology to achieve over 90% diagnostic accuracy. It complies with international standards and regulations, streamlining the diagnosis and treatment of cognitive disorders. Additionally, Braingaze offers BGaze Focus, a suite of gamified digital therapeutic tools designed to engage patients in managing symptoms of ADHD, ASD, and Dyslexia. These tools are accessible on mobile devices and enhance the therapy experience, particularly for children. Braingaze's solutions are used by healthcare providers, clinics, and hospitals across Europe, the UK, the US, and Canada, contributing to improved patient outcomes and communication.

• Employees 8
• Founded 2013
• Total Funding $2396498